Getting to First-in-Human for Small Molecules and Biologics

  Рет қаралды 4,343

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Designing First-In-Human Trials for Small Molecules and Biologics
37:34
Designing First-In-Human Trials for Small Molecules and Biologics
U.S. Food and Drug Administration
Рет қаралды 11 М.
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
44:31
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
U.S. Food and Drug Administration
Рет қаралды 12 М.
From Small To Giant 0%🍫 VS 100%🍫 #katebrush #shorts #gummy
00:19
From Small To Giant 0%🍫 VS 100%🍫 #katebrush #shorts #gummy
Kate Brush
Рет қаралды 13 МЛН
FOREVER BUNNY
00:14
FOREVER BUNNY
Natan por Aí
Рет қаралды 34 МЛН
Don’t Choose The Wrong Box 😱
00:41
Don’t Choose The Wrong Box 😱
Topper Guild
Рет қаралды 15 МЛН
coco在求救？ #小丑 #天使 #shorts
00:29
coco在求救？ #小丑 #天使 #shorts
好人小丑
Рет қаралды 63 МЛН
CMC Considerations for Biotechnology Product Development: A Regulatory Perspective
56:31
CMC Considerations for Biotechnology Product Development: A Regulatory Perspective
U.S. Food and Drug Administration
Рет қаралды 3,3 М.
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
36:56
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
U.S. Food and Drug Administration
Рет қаралды 7 М.
Updates on FDA’s Drug-Drug Interaction Final Guidances
1:24:58
Updates on FDA’s Drug-Drug Interaction Final Guidances
U.S. Food and Drug Administration
Рет қаралды 9 М.
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
54:28
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 16 М.
FDA Oncology Drug Development Overview - Past to Present
29:20
FDA Oncology Drug Development Overview - Past to Present
U.S. Food and Drug Administration
Рет қаралды 4,2 М.
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine
37:46
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine
U.S. Food and Drug Administration
Рет қаралды 3,2 М.
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
46:00
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 20 М.
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
28:12
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
U.S. Food and Drug Administration
Рет қаралды 10 М.
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (1 of 2)
2:19:09
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (1 of 2)
U.S. Food and Drug Administration
Рет қаралды 9 М.
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
1:20:20
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 23 М.
From Small To Giant 0%🍫 VS 100%🍫 #katebrush #shorts #gummy
00:19
From Small To Giant 0%🍫 VS 100%🍫 #katebrush #shorts #gummy
Kate Brush
Рет қаралды 13 МЛН